Cancer Policy Jacqueline Corrigan-Curay to retire as acting head of CDER at FDA June 27, 2025Vol.51 No.25By Claire Marie Porter
Cancer Policy RFK Jr.’s new committee votes on vaccine recommendations, despite Sen. Cassidy’s call for meeting delay June 27, 2025Vol.51 No.25By Claire Marie Porter and Jacquelyn Cobb
Cancer Policy “Forward funding” NIH budget plan would make competing for grants much harder June 20, 2025Vol.51 No.24By Claire Marie Porter
Cancer Policy Federal judge rules Trump directives canceling NIH grants “illegal,” orders them to be restored June 20, 2025Vol.51 No.24By Claire Marie Porter
Cancer Policy NIH Director Jay Bhattacharya launches a podcast June 20, 2025Vol.51 No.24By Claire Marie Porter
Cancer Policy FDA to issue “national priority vouchers” to companies supporting U.S. interests June 20, 2025Vol.51 No.24By Claire Marie Porter
Cancer Policy Vinay Prasad named chief medical and scientific officer at FDA June 20, 2025Vol.51 No.24By Claire Marie Porter
Cancer Policy FDA halts new clinical trials that export Americans’ cells to foreign labs in hostile countries June 20, 2025Vol.51 No.24By Claire Marie Porter
Cancer Policy In “Bethesda Declaration,” NIH employees, Nobel laureates say Bhattacharya is favoring politics over U.S. science, health June 13, 2025Vol.51 No.23By Jacquelyn Cobb
Cancer Policy AMA President Bobby Mukkamala, brain cancer survivor, says NIH research saved his life June 13, 2025Vol.51 No.23By Jacquelyn Cobb
